{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T17:58:07Z","timestamp":1776362287819,"version":"3.51.2"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R01AI095274"],"award-info":[{"award-number":["1R01AI095274"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.toxicon.2015.06.021","type":"journal-article","created":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T09:44:34Z","timestamp":1435743874000},"page":"37-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"special_numbering":"PA","title":["In\u00a0vivo onset and duration of action varies for botulinum neurotoxin A subtypes 1-5"],"prefix":"10.1016","volume":"107","author":[{"given":"Sabine","family":"Pellett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Tepp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina C.M.","family":"Whitemarsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marite","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2015.06.021_bib1","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.toxicon.2010.07.015","article-title":"Effects of A2 type botulinum toxin on spontaneous miniature and evoked transmitter release from the rat spinal excitatory and inhibitory synapses","volume":"56","author":"Akaike","year":"2010","journal-title":"Toxicon: Off. J. Int. Soc. Toxinol."},{"key":"10.1016\/j.toxicon.2015.06.021_bib2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1113\/jphysiol.2012.242131","article-title":"Transsynaptic inhibition of spinal transmission by A2 botulinum toxin","volume":"591","author":"Akaike","year":"2013","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.toxicon.2015.06.021_bib3","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1128\/AEM.01795-14","article-title":"Holotoxin activity of botulinum neurotoxin subtype A4 originating from a nontoxigenic Clostridium botulinum expression system","volume":"80","author":"Bradshaw","year":"2014","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.toxicon.2015.06.021_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2217\/pmt.13.75","article-title":"Botulinum toxin for neuropathic pain and spasticity: an overview","volume":"4","author":"Brown","year":"2014","journal-title":"Pain Manag."},{"key":"10.1016\/j.toxicon.2015.06.021_bib5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11910-014-0463-7","article-title":"Botulinum toxin for symptomatic therapy in multiple sclerosis","volume":"14","author":"Cameron","year":"2014","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"Suppl.\u00a03","key":"10.1016\/j.toxicon.2015.06.021_bib6","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/nau.22630","article-title":"Chapter 5: clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB)","volume":"33","author":"Cruz","year":"2014","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.toxicon.2015.06.021_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.mib.2012.05.012","article-title":"Clinical applications of botulinum toxin","volume":"15","author":"Dressler","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.toxicon.2015.06.021_bib8","doi-asserted-by":"crossref","first-page":"29604","DOI":"10.1074\/jbc.M703619200","article-title":"Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes","volume":"282","author":"Fischer","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.toxicon.2015.06.021_bib9","doi-asserted-by":"crossref","first-page":"10447","DOI":"10.1073\/pnas.0700046104","article-title":"Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes","volume":"104","author":"Fischer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.toxicon.2015.06.021_bib10","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1073\/pnas.0812839106","article-title":"Bimodal modulation of the botulinum neurotoxin protein-conducting channel","volume":"106","author":"Fischer","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.toxicon.2015.06.021_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-1605(94)00144-U","article-title":"The typing of botulinal neurotoxins","volume":"27","author":"Gimenez","year":"1995","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.toxicon.2015.06.021_bib12","first-page":"111","article-title":"Botulism","volume":"vol. 1","author":"Hatheway","year":"1988"},{"key":"10.1016\/j.toxicon.2015.06.021_bib13","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1021\/bi801686b","article-title":"Catalytic properties of botulinum neurotoxin subtypes A3 and A4 (dagger)","volume":"48","author":"Henkel","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.toxicon.2015.06.021_bib14","first-page":"1","article-title":"Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes","volume":"364","author":"Hill","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.toxicon.2015.06.021_bib15","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/JB.01180-06","article-title":"Genetic diversity among botulinum neurotoxin-producing clostridial strains","volume":"189","author":"Hill","year":"2007","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.toxicon.2015.06.021_bib16","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1128\/AEM.00201-11","article-title":"Purification, modeling and analysis of neurotoxin BoNT\/A5 from Clostridium botulinum strain A661222","volume":"77","author":"Jacobson","year":"2011","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.toxicon.2015.06.021_bib17","series-title":"Handbook of Clinical Neurology","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0072-9752(07)01511-4","article-title":"Chapter 11 botulism","volume":"vol. 91","author":"Johnson","year":"2008"},{"key":"10.1016\/j.toxicon.2015.06.021_bib18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fneur.2014.00098","article-title":"Spinal central effects of peripherally applied botulinum neurotoxin A in comparison between its subtypes A1 and A2","volume":"5","author":"Koizumi","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.toxicon.2015.06.021_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116381","article-title":"Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype, p e0116381","volume":"10","author":"Kull","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2015.06.021_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/AEM.01882-09","article-title":"Expression of the Clostridium botulinum A2 neurotoxin gene cluster proteins and characterization of the A2 complex","volume":"76","author":"Lin","year":"2010","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.toxicon.2015.06.021_bib21","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.1128\/AEM.01009-09","article-title":"Neurotoxin gene clusters in Clostridium botulinum type Ab strains","volume":"75","author":"Luquez","year":"2009","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.toxicon.2015.06.021_bib22","first-page":"27","article-title":"Purification of Clostridium botulinum type A neurotoxin","volume":"145","author":"Malizio","year":"2000","journal-title":"Methods Mol. Biol. Clift. NJ)"},{"key":"10.1016\/j.toxicon.2015.06.021_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pneurobio.2014.06.001","article-title":"Botulinum toxin A, brain and pain","volume":"119\u2013120","author":"Matak","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.toxicon.2015.06.021_bib24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.biochem.051908.125345","article-title":"Botulinum neurotoxin: a marvel of protein design","volume":"79","author":"Montal","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.toxicon.2015.06.021_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02131-14","article-title":"On botulinum neurotoxin variability","volume":"6","author":"Montecucco","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.toxicon.2015.06.021_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.toxicon.2013.12.012","article-title":"Comparison between botulinum neurotoxin type A2 and type A1 by electrophysiological study in healthy individuals","volume":"81","author":"Mukai","year":"2014","journal-title":"Toxicon"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.toxicon.2015.06.021_bib27","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/nau.22631","article-title":"Chapter 4: guidelines for the diagnosis and treatment of overactive bladder (OAB) and neurogenic detrusor overactivity (NDO)","volume":"33","author":"Nambiar","year":"2014","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.toxicon.2015.06.021_bib28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00018-013-1380-7","article-title":"The blockade of the neurotransmitter release apparatus by botulinum neurotoxins","volume":"71","author":"Pantano","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.toxicon.2015.06.021_bib29","first-page":"264","article-title":"A\u00a0review of prospective clinical trials for neurogenic bladder: pharmaceuticals","volume":"67","author":"Persu","year":"2014","journal-title":"Cent. Eur. J. Urol."},{"key":"10.1016\/j.toxicon.2015.06.021_bib30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.febslet.2010.11.045","article-title":"Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1","volume":"585","author":"Pier","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2015.06.021_bib31","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.celrep.2014.08.017","article-title":"Thioredoxin and its reductase are present on synaptic vesicles, and their inhibition prevents the paralysis induced by botulinum neurotoxins","volume":"8","author":"Pirazzini","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.toxicon.2015.06.021_bib32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrmicro3295","article-title":"Botulinum neurotoxins: genetic, structural and mechanistic insights","volume":"12","author":"Rossetto","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.toxicon.2015.06.021_bib33","first-page":"61","article-title":"Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity","volume":"364","author":"Rummel","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.toxicon.2015.06.021_bib34","first-page":"96","article-title":"Standardized assay for Clostridium botulinum toxins","volume":"61","author":"Schantz","year":"1978","journal-title":"J.\u00a0Assoc. Off. Anal. Chem."},{"key":"10.1016\/j.toxicon.2015.06.021_bib35","first-page":"257","article-title":"Intracellular targets and metalloprotease activity of tetanus and botulism neurotoxins","volume":"195","author":"Schiavo","year":"1995","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.toxicon.2015.06.021_bib36","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1128\/AEM.07967-11","article-title":"Purification and characterization of a novel subtype a3 botulinum neurotoxin","volume":"78","author":"Tepp","year":"2012","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.toxicon.2015.06.021_bib37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.toxicon.2010.10.009","article-title":"Comparison of effects of botulinum toxin subtype A1 and A2 using twitch tension assay and rat grip strength test","volume":"57","author":"Torii","year":"2010","journal-title":"Toxicon: Off. J. Int. Soc. Toxinol."},{"key":"10.1016\/j.toxicon.2015.06.021_bib38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1254\/jphs.11121FP","article-title":"Type A1 but not type A2 botulinum toxin decreases the grip strength of the contralateral foreleg through axonal transport from the toxin-treated foreleg of rats","volume":"117","author":"Torii","year":"2011","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.toxicon.2015.06.021_bib39","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/bcpt.12351","article-title":"Comparison of systemic toxicity between botulinum toxin subtypes A1 and A2 in mice and rats","volume":"116","author":"Torii","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.toxicon.2015.06.021_bib40","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/j.bbapap.2013.09.007","article-title":"Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5","volume":"1834","author":"Wang","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.toxicon.2015.06.021_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/nyas.12488","article-title":"Development of onabotulinumtoxinA for chronic migraine","volume":"1329","author":"Whitcup","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.toxicon.2015.06.021_bib42","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1128\/IAI.00536-13","article-title":"Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice","volume":"81","author":"Whitemarsh","year":"2013","journal-title":"Neuronal. Cell Cult. Vitro. Infect. Immun."},{"key":"10.1016\/j.toxicon.2015.06.021_bib43","doi-asserted-by":"crossref","first-page":"e90252","DOI":"10.1371\/journal.pone.0090252","article-title":"Persistence of botulinum neurotoxin a subtypes 1-5 in primary rat spinal cord cells","volume":"9","author":"Whitemarsh","year":"2014","journal-title":"PLoS One"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010115300027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010115300027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T02:59:29Z","timestamp":1537498769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010115300027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":43,"alternative-id":["S0041010115300027"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2015.06.021","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In\u00a0vivo onset and duration of action varies for botulinum neurotoxin A subtypes 1-5","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2015.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}